Reuters logo
10 months ago
BRIEF-Astellas Pharma files lawsuit against patent infringement of Myrbetriq in U.S.
October 7, 2016 / 1:27 AM / 10 months ago

BRIEF-Astellas Pharma files lawsuit against patent infringement of Myrbetriq in U.S.

1 Min Read

Oct 7 (Reuters) - Astellas Pharma Inc :

* Says the co and its subsidiaries jointly filed a lawsuit with the United States District Court against Actavis Elizabeth LLC and its affiliates, who filed an abbreviated new drug application for a generic version of Astellas' mirabegron (generic name) product sold under the trademark Myrbetriq in the U.S.

Source text in Japanese:goo.gl/wUwyaH

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below